Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617237 · ClinicalTrials.gov registry record
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
A clinical trial of Cancer, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT03617237 is a study of Cancer that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 10,000 participants, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03617237, a study of Cancer, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB) of the American College of Surgeon(ACS).
Conditions Studied
Interventions
- OTHER Retrospective Populations
Study Locations (1)
Texas
- UT Southwestern Medical Centre - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2012-07-03 |
| Est. Completion | 2032-04-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617237
The ClinicalTrials.gov registry entry for NCT03617237 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Retrospective Populations is the first listed.
NCT03617237 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03617237 about?
NCT03617237 is a clinical study titled "Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation". Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB...
What is the current status of trial NCT03617237?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2012-07-03. Estimated completion is 2032-04-18.
What conditions does trial NCT03617237 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT03617237?
The interventions under investigation include: Retrospective Populations (OTHER).
Who is sponsoring clinical trial NCT03617237?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617237 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
-
BfedBwell Optimization Pilot
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.